Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Abstract We evaluated the immunologic response to a novel vaccine regimen that included 2 doses of NVX-CoV2373 (Novavax) followed by 1 dose of BNT162b2 (Pfizer-BioNTech) monovalent booster vaccine. A durable neutralizing antibody response to Omicron BA.4/BA.5 and BA.1 variants was observed at month...

Full description

Bibliographic Details

Published in:	Open forum infectious diseases Vol. 11; no. 2; p. ofad673
Main Authors:	Babu, Tara M, Shen, Xiaoying, McClelland, R Scott, Wang, Zijun, Selke, Stacy, Wilkens, Chloe, Hauge, Kirsten A, McClurkan, Christopher L, Goecker, Erin, Laing, Kerry J, Koelle, David M, Greninger, Alexander L, Nussenzweig, Michel C, Montefiori, David C, Corey, Lawrence, Wald, Anna
Format:	Journal Article
Language:	English
Published:	US Oxford University Press 01-02-2024
Subjects:	Vaccines and Immunization SARS-CoV-2 vaccine antibody virus
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!